Survey of diabetes risk assessment tools: concepts, structure and performance

被引:20
|
作者
Thoopputra, Thitaporn [1 ]
Newby, David [2 ]
Schneider, Jennifer [1 ]
Li, Shu Chuen [1 ]
机构
[1] Univ Newcastle, Sch Biomed Sci & Pharm, Discipline Pharm & Expt Pharmacol, Newcastle, NSW 2300, Australia
[2] Univ Newcastle, Sch Med & Publ Hlth, Discipline Clin Pharmacol, Newcastle, NSW 2300, Australia
关键词
diabetes; risk assessment; screening; IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE INTERVENTION; IDENTIFYING INDIVIDUALS; EXTERNAL VALIDATION; SCORE; MELLITUS; QUESTIONNAIRE; PREDICTION; DERIVATION; ADULTS;
D O I
10.1002/dmrr.2296
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of this study is to review the effectiveness and limitations of existing diabetes risk screening tools to assess the need for further developing of such tools. An electronic search of the EMBASE, MEDLINE, and Cochrane library supplemented by a manual search was performed from 19952010. The search retrieved a total of 2168 articles reporting diabetes risk assessment tools which, after culling, produced 41 tools developed in 22 countries, with the majority (n?=?26) developed in North America and Europe. All are short questionnaires of 216 questions incorporating common variables including age, gender, waist circumference, BMI, family history of diabetes, history of hypertension or antihypertensive medications. While scoring format and cut-offs point are diverse between questionnaires, overall accuracy value range of 40-97%, 24-86% and 62-87% were reported for sensitivity, specificity and receiver operating characteristic curve respectively. In summary, there is a trend of increasing availability of diabetes prediction tools with the existing risk assessment tools being generally a short questionnaire aiming for ease of use in clinical practice. The overall performance of existing tools showed moderate to high accuracy in their predictive performance. However, further detailed comparison of existing questionnaires is needed to evaluate whether they can serve adequately as diabetes risk assessment tool in clinical practice. Copyright (c) 2012 John Wiley & Sons, Ltd.
引用
收藏
页码:485 / 498
页数:14
相关论文
empty
未找到相关数据